InvestorsHub Logo
Followers 1
Posts 136
Boards Moderated 0
Alias Born 10/27/2016

Re: None

Wednesday, 09/09/2020 10:26:21 PM

Wednesday, September 09, 2020 10:26:21 PM

Post# of 18608
Looks like other companies move forward, but HDC just sits idle and gets sued. Interesting how this company is marketing this test. At what point do HDC directors step aside, realizing that shareholders have caught on to their act?

miR Scientific’s Sentinel™ Test is the only standalone, non-invasive liquid biopsy urine test that accurately detects, classifies and monitors prostate cancer at the molecular level with 95% Sensitivity and Specificity.